A Waterlooville father who lost his wife to bowel cancer after living with colitis for more than half her life, has welcomed ...

Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

DNA testing may inform treatment decisions and predict outcomes of adjuvant chemotherapy in patients with stage II-III colorectal cancer.

Jan. 28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their blood after surgery to remove the ...

Medicare also pays for some chemotherapy drugs through Part D. A person with Medicare Advantage, also known as Medicare Part C, must have at least the same coverage as a person with Original ...

Surgery will continue to be “the standard of care therapy for patients with colon cancer,” Oberstein said, adding that the current study recommended surgery regardless of the treatment.

NEW YORK, February 04, 2025 -- ( BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter and ...

There are many potential symptoms of colon cancer. Some are mild, and others may be more alarming. It’s important to speak with your doctor or healthcare professional if you have any of these ...

Although cancer chemotherapy and radiotherapy is often viewed as a strategy that mainly affects tumour cells, accumulating evidence indicates that cytotoxic drugs also affect the immune system to ...